🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Combined modality approach using Obitunuzumab and involved site low dose ir...
Status
Completed
Location
University of Tuebingen
Start Date
2018-04-24
Trial ID
NCT03341520
Treatments Being Tested
To evaluate the efficacy and safety of CAGM regimen in R/R DLBCL patients a...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2022-09-30
Trial ID
NCT05823701
Treatments Being Tested
This global, multicenter, open-label study will evaluate the safety and tol...
Status
Completed
Location
HonorHealth Research Institute - Bisgrove
Start Date
2014-08-18
Trial ID
NCT02174172
Treatments Being Tested
A study of acalabrutinib plus venetoclax (AV) versus venetoclax plus obinut...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-09-12
Trial ID
NCT05057494
Treatments Being Tested
Lupus nephritis (LN) is a frequent and severe complication of systemic lupu...
Status
Not Yet Recruiting
Location
Sorbonne University - Nephrology Départment - Tenon APHP
Start Date
2026-09-02
Trial ID
NCT07721363
Treatments Being Tested
This is a Phase I/II interventional, open-label treatment study designed to...
Status
Recruiting
Location
Hematology/Oncology department
Start Date
2024-05-14
Trial ID
NCT06762431
Treatments Being Tested
This study intends to use Obinutuzumab, Zanubrutinib, and Lenalidomide sequ...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2022-07-01
Trial ID
NCT05797948
Follicular lymphoma (FL) is the second most common B-cell cancer and the mo...
Status
Active Not Recruiting
Location
UCSF Fresno /ID# 264712
Start Date
2024-02-05
Trial ID
NCT06191744
The anti-CD20 monoclonal antibodies, rituximab (R) and obinutuzumab (G), ar...
Status
Completed
Location
Centre Henri Becquerel
Start Date
2021-05-21
Trial ID
NCT04918940
Treatments Being Tested
The primary objective of this study is to characterize the safety and toler...
Status
Active Not Recruiting
Location
University of California San Francisco - Fresno Center for Medical Education and Research
Start Date
2022-06-17
Trial ID
NCT04970901
Treatments Being Tested